Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium

Por Seferina, Shanly C., de Boer, Maaike, Derksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., Joore, Manuela, Peer, Petronella G.M., Voogd, Adri C., Tjan-Heijnen, Vivianne C.G.
Publicado no Oncologist (2016)

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium

Por Seferina, Shanly C., Ramaekers, Bram L.T., de Boer, Maaike, Dercksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., Voogd, Adri C., Tjan Heijnen, Vivianne C.G., Joore, Manuela A.
Publicado no Oncotarget (2017)

Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium

Por Seferina, Shanly C., Lobbezoo, Dorien J.A., de Boer, Maaike, Dercksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., de Vries, Bart, Joore, Manuela A., Peer, Petronella G.M., Voogd, Adri C., Tjan-Heijnen, Vivianne C.G.
Publicado no Oncologist (2015)